567 related articles for article (PubMed ID: 22236965)
21. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
22. Circulating Th17, Th22, and Th1 cells are increased in psoriasis.
Kagami S; Rizzo HL; Lee JJ; Koguchi Y; Blauvelt A
J Invest Dermatol; 2010 May; 130(5):1373-83. PubMed ID: 20032993
[TBL] [Abstract][Full Text] [Related]
23. Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.
Sofen H; Smith S; Matheson RT; Leonardi CL; Calderon C; Brodmerkel C; Li K; Campbell K; Marciniak SJ; Wasfi Y; Wang Y; Szapary P; Krueger JG
J Allergy Clin Immunol; 2014 Apr; 133(4):1032-40. PubMed ID: 24679469
[TBL] [Abstract][Full Text] [Related]
24. The role of IL-17 in psoriasis.
Malakouti M; Brown GE; Wang E; Koo J; Levin EC
J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
[TBL] [Abstract][Full Text] [Related]
25. Genetic proof for the transient nature of the Th17 phenotype.
Kurschus FC; Croxford AL; Heinen AP; Wörtge S; Ielo D; Waisman A
Eur J Immunol; 2010 Dec; 40(12):3336-46. PubMed ID: 21110317
[TBL] [Abstract][Full Text] [Related]
26. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis.
Singh TP; Schön MP; Wallbrecht K; Gruber-Wackernagel A; Wang XJ; Wolf P
PLoS One; 2013; 8(1):e51752. PubMed ID: 23335955
[TBL] [Abstract][Full Text] [Related]
27. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.
Eysteinsdóttir JH; Sigurgeirsson B; Ólafsson JH; Fridriksson T; Agnarsson BA; Davíðsson S; Valdimarsson H; Lúðvíksson BR
Scand J Immunol; 2013 Dec; 78(6):529-37. PubMed ID: 24111693
[TBL] [Abstract][Full Text] [Related]
28. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis.
Luan L; Han S; Wang H; Liu X
Int Immunopharmacol; 2015 Dec; 29(2):278-284. PubMed ID: 26585971
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
31. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis].
Han LN; Li TL; Zhang YJ; Yang TS; Ding Y; Guo SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):751-6. PubMed ID: 22332535
[TBL] [Abstract][Full Text] [Related]
32. Small Extracellular Vesicles Containing miR-381-3p from Keratinocytes Promote T Helper Type 1 and T Helper Type 17 Polarization in Psoriasis.
Jiang M; Fang H; Dang E; Zhang J; Qiao P; Yu C; Yang A; Wang G
J Invest Dermatol; 2021 Mar; 141(3):563-574. PubMed ID: 32712160
[TBL] [Abstract][Full Text] [Related]
33. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
[TBL] [Abstract][Full Text] [Related]
34. Characterization of lesional psoriatic skin T lymphocyte clones.
Barna M; Snijdewint FG; van der Heijden FL; Bos JD; Kapsenberg ML
Acta Derm Venereol Suppl (Stockh); 1994; 186():9-11. PubMed ID: 8073850
[TBL] [Abstract][Full Text] [Related]
35. Effects of histamine on Th1/Th2 cytokine balance.
Packard KA; Khan MM
Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity.
Jacob SE; Nassiri M; Kerdel FA; Vincek V
Mediators Inflamm; 2003 Oct; 12(5):309-13. PubMed ID: 14760939
[TBL] [Abstract][Full Text] [Related]
37. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris.
Zhu K; Ye J; Wu M; Cheng H
Arch Dermatol Res; 2010 Sep; 302(7):517-23. PubMed ID: 20333526
[TBL] [Abstract][Full Text] [Related]
38. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
Lubberts E
Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
Michalak-Stoma A; Bartosińska J; Kowal M; Juszkiewicz-Borowiec M; Gerkowicz A; Chodorowska G
Dis Markers; 2013; 35(6):625-31. PubMed ID: 24288431
[TBL] [Abstract][Full Text] [Related]
40. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
